We are live on ! Find out more

PBLS

Parabilis Medicines, Inc. Common Stock

PBLS

Market cap $3.2B

Upgrade to unlock

Positive

Neutral

Negative

Sentiment 3-Months

Positive

Neutral 0%

Negative

The Motley Fool

Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock?

Parabilis and another recent IPO stock each raised more than Moderna -- which had previously been the biggest biotech IPO. Parabilis' technology could be a game changer and potentially used across treatment areas.

Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock?

See News Rankings